1. Home
  2. AIN vs MLYS Comparison

AIN vs MLYS Comparison

Compare AIN & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Albany International Corporation

AIN

Albany International Corporation

N/A

Current Price

$67.15

Market Cap

1.8B

ML Signal

N/A

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

N/A

Current Price

$18.32

Market Cap

1.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AIN
MLYS
Founded
1895
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Textiles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.9B
IPO Year
1994
2023

Fundamental Metrics

Financial Performance
Metric
AIN
MLYS
Price
$67.15
$18.32
Analyst Decision
Hold
Strong Buy
Analyst Count
3
11
Target Price
★ $67.67
$46.33
AVG Volume (30 Days)
203.1K
★ 1.3M
Earning Date
10-28-2026
11-04-2026
Dividend Yield
★ 1.72%
N/A
EPS Growth
N/A
★ 37.43
EPS
★ 2.60
N/A
Revenue
★ $1,054,132,000.00
N/A
Revenue This Year
$10.54
N/A
Revenue Next Year
$6.33
N/A
P/E Ratio
$56.54
★ N/A
Revenue Growth
★ 7.29
N/A
52 Week Low
$41.15
$20.12
52 Week High
$77.00
$47.65

Technical Indicators

Market Signals
Indicator
AIN
MLYS
Relative Strength Index (RSI) 68.03 30.11
Support Level $58.46 N/A
Resistance Level $76.78 $31.19
Average True Range (ATR) 1.71 1.33
MACD 0.44 0.01
Stochastic Oscillator 88.82 3.62

Price Performance

Historical Comparison
AIN
MLYS

About AIN Albany International Corporation

Albany International Corp is a textiles and materials processing company specializing in engineered fabrics and composite components and assemblies for the paper, industrial manufacturing and aerospace industries. It operates through two segments: Machine Clothing, which produces custom-designed fabrics and high-speed process belts for paper, paperboard, tissue, towel and pulp, as well as engineered fabrics for other industrial applications, and contributes the majority of revenue; and Albany Engineered Composites, which provides engineered composite parts for the aerospace and defense industries. The company generates revenue from the United States, Switzerland, Brazil, China, Mexico, France and other areas.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.

Share on Social Networks: